Reticulocyte Hemoglobin Test · Blood

Most iron problems are caught late. By the time hemoglobin drops or you feel the fatigue, your body has been running short on iron for weeks or months. RET-He (reticulocyte hemoglobin equivalent) gives you a near real-time read on iron supply by measuring how much hemoglobin is packed into your newest red blood cells, the ones your bone marrow produced in the last day or two.

Because reticulocytes circulate for only one to two days, this number reflects what your body is doing with iron right now, not weeks ago. It moves earlier than hemoglobin and is harder to fool than ferritin in the presence of inflammation, making it one of the cleanest windows into iron-restricted blood production available from a routine blood draw.

What This Test Actually Measures

Reticulocytes are the youngest red blood cells released from your bone marrow. They circulate for only one to two days before maturing into adult red blood cells. RET-He measures the average hemoglobin content of these newcomers, reported in picograms per cell. Because hemoglobin can only be built when iron is available, the number directly reflects how much iron your marrow has on hand to make new blood cells.

This is what makes the marker useful. Standard ferritin can look normal or even elevated when you have low iron stores, because ferritin rises with inflammation, infection, and chronic disease. RET-He is largely unaffected by these acute-phase reactions and remains a reliable signal of iron-restricted blood production even when other tests are distorted.

Why It Matters: Iron Deficiency Anemia

In a study of 309 adults, RET-He picked up iron deficiency anemia (IDA) with 87.8% sensitivity and 77.7% specificity at a cutoff of 30.15 pg, meaning it correctly flagged about 88 out of 100 people who actually had iron deficiency anemia. In a larger study of 953 individuals, values above 30 pg effectively ruled out iron deficiency anemia. In adults, lower RET-He levels are associated with higher risk of iron deficiency anemia, while normal levels strongly reduce that risk.

What this means for you: a low value here is one of the earliest reliable signs that your body cannot supply enough iron to make healthy red blood cells, often before you feel symptoms or before hemoglobin starts to fall.

Catching Iron Deficiency Before Anemia Develops

Iron deficiency exists on a spectrum. Stores deplete first, then iron supply to the marrow drops, and only later does hemoglobin fall. RET-He can identify the middle stage. In a study of 182 individuals, cutoffs of below 28.3 pg detected iron deficiency without anemia, and below 21.6 pg detected full iron deficiency anemia, with very high diagnostic accuracy (area under the curve of 0.94 to 0.99, where 1.0 would be perfect).

In non-anemic adults, RET-He detected iron deficiency with good accuracy when ferritin alone was insufficient. This is the kind of early read a standard CBC and ferritin combination often misses, especially in people with inflammation or chronic conditions that distort ferritin.

Kidney Disease and Hemodialysis

In people on hemodialysis, RET-He outperforms ferritin and transferrin saturation (TSAT, a standard iron measurement) for detecting functional iron deficiency, where iron exists in storage but cannot reach the marrow fast enough. In a study of 355 hemodialysis patients, RET-He proved more effective than ferritin and TSAT in detecting iron deficiency. A separate study of 69 dialysis patients confirmed RET-He effectively predicted iron deficiency in this setting.

What this means for you: if you have chronic kidney disease, ferritin is unreliable because it rises with the inflammation of kidney disease itself. RET-He cuts through that noise.

Heart Failure and Critical Illness

In a study of 142 heart failure patients, RET-He identified iron deficiency and predicted who would respond to intravenous iron therapy. In intensive care, where ferritin is essentially useless because almost everyone has acute inflammation, a study of 40 ICU patients showed RET-He and a related index called Delta-He outperformed ferritin in predicting anemia development.

Inflammatory Bowel Disease

In a study of 124 people with inflammatory bowel disease, RET-He reliably assessed whether iron was actually reaching the marrow for blood production. This matters because IBD causes both blood loss and chronic inflammation, the exact combination that makes ferritin misleading.

Children, Infants, and Pregnancy

In a study of 970 children, RET-He served as a reliable screening marker for iron deficiency and iron deficiency anemia. In healthy 9 to 12-month-old infants, a study of 202 babies found that a CHr (an older name for the same measurement) below 27.5 pg was a more accurate indicator of iron deficiency than hemoglobin and predicted later development of anemia. In healthy Chinese children under 5 years, a cutoff of 27.8 pg identified iron deficiency, with infants showing lower levels than older age groups.

In premature and very low birthweight infants, levels drop more sharply in the first days of life than in term infants, reflecting high iron demand during rapid growth.

Reference Ranges

Cutoffs vary by population, age, and the specific analyzer used. The values below come from published research in different groups and serve as orientation, not absolute targets. Your lab may report slightly different cutpoints depending on the instrument.

Sources: Chinudomwong et al. 2020 (n=953); Alzu'bi et al. 2023 (n=309); Almashjary et al. 2022 (n=182); Tung et al. 2024 (n=946); Ullrich et al. 2005 (n=202).

What this means for you: compare your results within the same lab over time for the most meaningful read. A single value below a published cutoff should prompt investigation, not panic.

Tracking Your Trend

This marker is uniquely well suited to serial tracking because it changes fast. RET-He responds within about a week of starting iron therapy, faster than hemoglobin. In a randomized trial of 356 Cambodian women given 60 mg of elemental iron daily, RET-He levels at one week strongly predicted who would show a meaningful hemoglobin response. In hemodialysis patients, biological variation within the same person is low, around 4.8% (compared to 38.2% for transferrin saturation and 15.1% for ferritin), meaning a single measurement is reasonably representative of your typical value.

A reasonable cadence: get a baseline, retest in one to four weeks if you start iron therapy to confirm response, and at least annually for ongoing monitoring. If you have inflammatory bowel disease, kidney disease, heavy menstrual bleeding, or are pregnant, retest every three to six months.

What to Do If Your Result Is Low

A low value points to iron-restricted blood production but does not by itself tell you why. The next step is to order companion tests to identify the cause: ferritin (for iron stores), transferrin saturation and total iron-binding capacity (for iron transport), CRP or hs-CRP (high-sensitivity C-reactive protein, to check for inflammation that distorts ferritin), and a complete blood count with red cell indices (to assess whether anemia has developed).

If iron deficiency is confirmed, the cause needs investigation. In adults, this means ruling out gastrointestinal blood loss (which may need a colonoscopy or endoscopy), heavy menstrual bleeding, dietary inadequacy, or absorption issues like celiac disease. A primary care physician, hematologist, or gastroenterologist can guide the workup. If your result is normal but you still feel fatigued or short of breath, the cause is likely something other than iron deficiency, and that itself is useful information.

When Results Can Be Misleading

A few situations can produce results that do not reflect your true iron status:

• Other red blood cell disorders: in conditions like thalassemia or when the average red cell size is very high, RET-He becomes harder to interpret accurately.
• Recent transfusion or acute hemolysis: rapid red blood cell turnover from drug-induced hemolysis (some antibiotics, chemotherapy agents, and immune checkpoint inhibitors can trigger this) can distort the picture by changing the proportion of young cells.
• Bone marrow suppression from medication: linezolid (an antibiotic) and similar agents can suppress red blood cell production, lowering the count of reticulocytes available to measure.
• Drugs that stimulate red blood cell production: SGLT2 inhibitors (a class of diabetes medications), HIF-prolyl hydroxylase inhibitors (used for kidney disease anemia), and erythropoiesis-stimulating agents temporarily boost reticulocyte production, which can shift the reading independent of your underlying iron status.

How to Use This Test

Think of RET-He as your earliest warning system for iron-restricted blood production. It is most valuable when ordered alongside ferritin, transferrin saturation, and a complete blood count, especially if you have a chronic condition (kidney disease, heart failure, IBD), are a menstruating or pregnant woman, are an endurance athlete, or have unexplained fatigue. A normal value is reassuring. A low value, especially when ferritin is also low or when ferritin is inflated by inflammation, is your cue to act before anemia develops.